🔎 Trials Near Me

Akèy › Maladi poumon entèstisyèl › Oklahoma

Etid klinik pou Maladi poumon entèstisyèl nan Oklahoma

5 etid pou Maladi poumon entèstisyèl ap chèche patisipan nan sit nan Oklahoma.

Vil nan Oklahoma

Tèks ofisyèl etid la (Anglè)

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

  • University of Oklahoma, Oklahoma City
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06911632

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • The University of Oklahoma Health Sciences Center, Oklahoma City
  • Oklahoma Heart Institute, Tulsa
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT06388421

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

  • University of Oklahoma, Oklahoma City
Ap rekriteEtid obsèvasyon
Laj 21 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT01915511

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

  • University of Oklahoma Health Sciences Center (OUHSC), Oklahoma City
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Nov 12, 2025 · NCT05975983

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

  • aTyr Investigative Site, Oklahoma City
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 7, 2025 · NCT05892614

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.